These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12747599)
1. PON1-192 phenotype and genotype assessments in 918 subjects of the Stanislas cohort study. Vincent-Viry M; Sass C; Bastien S; Aguillon D; Siest G; Visvikis S Clin Chem Lab Med; 2003 Apr; 41(4):535-40. PubMed ID: 12747599 [TBL] [Abstract][Full Text] [Related]
2. Paraoxonase polymorphism in northwestern Indians. Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059 [TBL] [Abstract][Full Text] [Related]
3. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis. Singh S; Verma M; Nain CK; Leelamma CO; Goel RC Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101 [TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Juretić D; Tadijanović M; Rekić B; Simeon-Rudolf V; Reiner E; Baricić M Croat Med J; 2001 Apr; 42(2):146-50. PubMed ID: 11259735 [TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients. Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140 [TBL] [Abstract][Full Text] [Related]
6. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes. Mahrooz A; Alizadeh A; Gohari G J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930 [TBL] [Abstract][Full Text] [Related]
7. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population. Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186 [TBL] [Abstract][Full Text] [Related]
8. Paraoxonase phenotype distribution in a healthy Iranian population. Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311 [TBL] [Abstract][Full Text] [Related]
9. The human serum paraoxonase/arylesterase polymorphism. Eckerson HW; Wyte CM; La Du BN Am J Hum Genet; 1983 Nov; 35(6):1126-38. PubMed ID: 6316781 [TBL] [Abstract][Full Text] [Related]
10. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
11. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651 [TBL] [Abstract][Full Text] [Related]
12. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735 [TBL] [Abstract][Full Text] [Related]
14. Determination of paraoxonase (PON1) status requires more than genotyping. Richter RJ; Furlong CE Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report. Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815 [TBL] [Abstract][Full Text] [Related]
16. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men. Marchesani M; Hakkarainen A; Tuomainen TP; Kaikkonen J; Pukkala E; Uimari P; Seppälä E; Matikainen M; Kallioniemi OP; Schleutker J; Lehtimäki T; Salonen JT J Natl Cancer Inst; 2003 Jun; 95(11):812-8. PubMed ID: 12783936 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene. Sentí M; Aubó C; Tomás M Metabolism; 2000 May; 49(5):557-9. PubMed ID: 10831161 [TBL] [Abstract][Full Text] [Related]
18. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
19. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395 [TBL] [Abstract][Full Text] [Related]